Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19

M Khoury, J Cuenca, FF Cruz… - European respiratory …, 2020 - Eur Respiratory Soc
The severe respiratory consequences of the coronavirus disease 2019 (COVID-19)
pandemic have prompted urgent need for novel therapies. Cell-based approaches, primarily …

Immunomodulatory properties of mesenchymal stromal cells: an update

L Müller, A Tunger, M Wobus, M von Bonin… - Frontiers in cell and …, 2021 - frontiersin.org
Mesenchymal stromal cells (MSCs) are characterized by an extraordinary capacity to
modulate the phenotype and functional properties of various immune cells that play an …

Mesenchymal stem cell immunomodulation: In pursuit of controlling COVID-19 related cytokine storm

N Song, H Wakimoto, F Rossignoli, D Bhere… - Stem Cells, 2021 - academic.oup.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has grown to be a global
public health crisis with no safe and effective treatments available yet. Recent findings …

Current status of mesenchymal stem cell therapy for immune/inflammatory lung disorders: Gleaning insights for possible use in COVID-19

BL Yen, ML Yen, LT Wang, KJ Liu… - Stem cells translational …, 2020 - academic.oup.com
The broad immunomodulatory properties of human mesenchymal stem cells (MSCs) have
allowed for wide application in regenerative medicine as well as immune/inflammatory …

Mesenchymal stromal cells and viral infection

M Thanunchai, S Hongeng… - Stem Cells …, 2015 - Wiley Online Library
Mesenchymal Stromal Cells (MSCs) are a subset of nonhematopoietic adult stem cells,
readily isolated from various tissues and easily culture‐expanded ex vivo. Intensive studies …

mesenchymal stromal cell therapy for inflammatory bowel diseases

C Grégoire, C Lechanteur, A Briquet… - Alimentary …, 2017 - Wiley Online Library
Background Inflammatory bowel diseases (IBD) are chronic relapsing diseases in which pro‐
inflammatory immune cells and cytokines induce intestinal tissue damage and disability …

Stem cell therapy: a potential approach for treatment of influenza virus and coronavirus-induced acute lung injury

J Du, H Li, J Lian, X Zhu, L Qiao, J Lin - Stem cell research & therapy, 2020 - Springer
Acute lung injury (ALI), an increasingly devastating human disorder, is characterized by a
multitude of lung changes arising from a wide variety of lung injuries. Viral infection is the …

Immunomodulatory effects of mesenchymal stem cells on leukocytes with emphasis on neutrophils

F Salami, A Tavassoli, J Mehrzad, A Parham - Immunobiology, 2018 - Elsevier
Mesenchymal stem cells (MSCs) are a population of multipotent cells with the ability of
expansion and plastic-adherence in vitro. MSCs can differentiate into chondrocytes …

Remestemcel-L for the treatment of graft versus host disease

F Locatelli, M Algeri, V Trevisan… - Expert review of clinical …, 2017 - Taylor & Francis
Introduction: Remestemcel-L, a third-party, off-the-shelf preparation of bone-marrow derived
mesenchymal stromal cells (MSCs), has been developed for experimental use in acute graft …

Immunomodulatory effect of CD200-positive human placenta-derived stem cells in the early phase of stroke

TH Kong, JM Park, JH Jang, CY Kim, SH Bae… - … & Molecular Medicine, 2018 - nature.com
Human placenta amniotic membrane-derived mesenchymal stem cells (AMSCs) regulate
immune responses, and this property can be exploited to treat stroke patients via cell …